FDA requires new physician labels for Levaquin


The FDA requires new safety information with the use of Levaquin, particularly the increased risks of tendonitis and tendon rupture. Read about the new requirements here.

0 Comments Posted

Post A Comment

Register to post a comment or sign in below.

Email Address (will not be displayed)

« Read more related news


THL Blog Team

Posted by

THL Blog Team

No-Obligation Free Consultation

Contact us by phone at (618) 656-4400 or email us below.


Your information will be used only so that we may contact you to evaluate your case. Your contact information will never be shared or sold to anyone other than TorHoerman Law.